Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

PharmiWeb

- PMLiVE

Merck’s adult-specific pneumococcal vaccine Capvaxive recommended by CHMP

Diseases caused by Streptococcus pneumoniae bacteria are considered a “major public health problem” by WHO

- PMLiVE

GenAI and healthcare – potential that goes beyond established technologies

With intuitive interfaces, the ability to handle vast and complex unstructured data and impressive versatility, GenAI is gaining traction

- PMLiVE

Uniphar Expands Global Footprint with Three New Facilities in the USA, Netherlands and Ireland

[Dublin, 05 February 2025] Global partner to pharmaceutical and medtech manufacturers, Uniphar, is expanding its international presence with the launch of three new, state-of-the-art facilities, strategically positioned across key global...

Uniphar

Accession Logo

Accession announces major UK market access consulting milestone

February 5th 2025: Today Accession Healthcare Consulting Ltd (Accession) has announced the achievement of a major consulting milestone as it enters its 15th year as a specialist provider of UK...

Accession

- PMLiVE

UK government launches ‘landmark’ AI breast cancer screening trial

Approximately 55,000 cases of the disease are diagnosed every year in the UK

- PMLiVE

World Cancer Day – CoppaFeel! and NHS NELCA urge young people to ‘Check In’

The co-designed campaign aims to challenge misconceptions surrounding breast cancer

- PMLiVE

Pfizer announces positive phase 3 results for Braftovi regimen in colorectal cancer

An estimated 154,270 people will be diagnosed with cancer of the colon or rectum in the US this year

- PMLiVE

BMS receives CHMP recommendation for Opdivo/Yervoy combination in liver cancer

Hepatocellular carcinoma accounts for approximately 90% of all liver cancer cases globally

- PMLiVE

Celebrating collective achievement – the power of collaboration

How partnerships in the pharma industry have become a cornerstone of progress

- PMLiVE

FlyPharma 2025 Amsterdam officially announced as contracts are signed with host sponsors

The conference will take place in Amsterdam from 8-9 October 2025

- PMLiVE

AstraZeneca’s Imfinzi recommended by CHMP to treat small cell lung cancer

Approximately 30% of small cell lung cancer patients have limited-stage disease

- PMLiVE

J&J’s subcutaneous Rybrevant receives positive CHMP opinion for advanced lung cancer

The formulation significantly reduces administration time compared to the approved intravenous version

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links